The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Grund Nicholas since 2025.
This trader's CIK number is 1661887.
At the time of last reporting, Grund Nicholas was the Chief Commercial Officer of Akebia Therapeutics, Inc.. (stock ticker symbol AKBA).
Also see all insider trading activities at Akebia Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | AKBA | 0 | $0 | 55,621 | $116,804 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-02-03 | AKBA | Sale | 55,621 | 2.10 | 116,804 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Grund Nicholas (Chief Commercial Officer of Akebia Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.